Skip to content
Researchers
Search UMMC
Mobile Navigation
UMMC Navigation
⌂
UMMC Home
Education
Academic Affairs
For Prospective Students
For Students
For Residents and Fellows
For Faculty
School of Dentistry
School of Graduate Studies
School of Health Related Professions
School of Medicine
School of Nursing
School of Population Health
UMMC Online
Faculty Directory
Health Care
Health Care Home
All UMMC Services
Children's of Mississippi
Find a Doctor
Find a Location
Pay a Bill
UMMC Pricing
Patient and Visitor Information
Referring Physicians
Research
Research Home
Centers and Institutes
Offices
Resources
Participate in Clinical Trials
About
A-Z Site Index
About Us
Accreditations
History
Jobs at UMMC
Leadership
Mission and Vision
Give
MyChart
Appointments
Researchers
Participants
Participants
How to Participate in Clinical Trials
Become a Participant
Frequently Asked Questions
Clinical Trials
Find a Trial - Clinical Trials Database
Research Resources for Participants
Contact Us
More contact information
Researchers
Researchers
Researchers Home
Researcher Road Map
Study Assessment
Study Start-Up
Study Conduct
Study Closure
Office of Research
Home
Clinical Trials Database
Contact Us
More contact information
Sponsors
Research
Research Offices
Office of Clinical Trials
Researchers
Researcher Road Map
Study Conduct
Participant Management
Participant Management
Researchers Home
Researcher Road Map
Research Study Road Map Home
Study Assessment
Study Assessment Home
Confidential Disclosure Agreement
Protocol Development/Review
Site Qualification
Accrual Feasibility
Recruitment Plan
Logistics
Informed Consent Form Design
Financial Disclosure/Conflicts of Interest
Study Start-Up
Study Start-Up Home
Study Activation
Study Activation Home
Activation of Clinical Trials (ACT) Process
Budget
IRB, IBC, and RSC Review
Clinical Trial/Study Agreement
ClinicalTrials.gov Registration
Study Set-Up
Study Set-Up Home
Study Operations Planning
Data Collection Plan
Regulatory Files
Staff Training and Delegation
Lab
CRTU
Research Billing
Investigational Drug Service
Velos CTMS
Velos FAQs
Site Initiation
Study Conduct
Study Conduct Home
Participant Recruitment
Participant Recruitment Home
Advertising
Recruitment
Screening
Consenting
Participant Management
Participant Management Home
Velos CTMS
Biospecimen Management
Participant Follow-Up
Remuneration/Reimbursement
Research Billing
Maintaining Participant Records
Data Collection
Safety Monitoring
Reconsenting
Monitoring Consent Status
Study Oversight, Maintenance and Reporting
Study Oversight, Maintenance and Reporting Home
Regulatory File Maintenance
IRB Continuing Review
Amendments
Reportable Events
Regulatory Reporting
Data Management
Data Query Resolution
Study Monitoring/Audits
Budget Management
Study Closure
Study Closure Home
Study Close-Out Visit
IRB Closure
Archiving Records
Clinicaltrials.gov Closure
Post-Award Closure
Training
Training Home
Clinical Research Professionals Group
CREW Program
Main Content
Safety Monitoring
DEFINITION
Safety Monitoring
includes provisions for monitoring of data collected for scientific validity and safety of research participants.
Monitoring, in general, is the act of overseeing the progress of a clinical study and of ensuring that it is conducted, recorded, and reported in accordance with the protocol, SOPs, GCP and applicable regulatory requirement(s).
Policies/Guidelines
For research that involves greater than minimal risk, the investigator should submit a data and safety monitoring (DSM) plan along with the IRB application.
The DSM plan should describe the procedures for safety monitoring, reporting of unanticipated problems involving risks to participants or others, descriptions of interim safety reviews and the procedures planned for providing monitoring results to the IRB.
DSM may be performed by a researcher, medical monitor, safety monitoring committee, or other means, as appropriate.
Templates/Forms
Data and Safety Monitoring plans should specify:
The entity or person(s) who will perform the monitoring, and the independence or affiliation that the entity or person(s) has with the sponsor or investigator;
The safety information that will be collected and monitored, including serious adverse events and unanticipated problems;
The frequency of review of safety data;
The procedure for analysis and interpretation of the data;
The procedure for review of scientific literature and data from other sources that may inform the safety or conduct of the study;
The conditions that will trigger a suspension or termination of the research (i.e., stopping rules), if applicable;
The procedure for reporting to the IRB, including a summary description of what information, or type of information, will be provided.
Training:
See 10.3.4 Data and Safety Monitoring f the University of Mississippi Medical Center Standard Operating Procedures Human Research Protection Program (HRPP), April 26, 2019.
University of Mississippi Medical Center Standard Operating Procedures Human Research Protection Program (HRPP), April 26, 2019.